Dispensing a Compounded Ointment with an Unverified Ingredient
A pharmacy attached to a traditional medicine clinic receives a request to compound a 50 g wound-healing ointment from a handwritten formula: beeswax base, olive oil, and 'saffron extract' at 2%. The saffron stock on the shelf is in an unlabeled jar with no batch number, no supplier record, and no expiry date; it was decanted from a larger container last year. The patient has a 3 cm superficial abrasion on the forearm, clean, no signs of infection. The clinic's quality-control log has not been completed for three months. A junior dispenser asks whether to proceed because 'it's only a small wound.'
1. Should the ointment be compounded with the current saffron stock? Give your decision and the specific quality-control failures involved.
Read the worked answer
Decision: No - do not compound with the unlabeled saffron stock.
Quality-control failures:
- Identity not verifiable - no label, no batch number; the material cannot be confirmed as saffron (Crocus sativus stigma) rather than an adulterant. Saffron is one of the most commonly adulterated botanicals, often substituted with safflower or dyed plant material.
- No supplier or traceability record - recall or investigation would be impossible.
- No expiry date - stability and microbial status unknown after a year in an open jar.
- Broken QC log - three months without records means the whole stock's integrity is in question, not just this jar.
The small wound size is irrelevant: the risk is to the product's identity and safety, not the wound's severity. A clean abrasion does not justify using unverified material.
2. Outline the corrective actions you would take before any further compounding, and how you would explain the delay to the patient.
Read the worked answer
Corrective actions:
- Quarantine and clearly label the unlabeled saffron as 'DO NOT USE - pending verification'; segregate it from usable stock.
- Restore the QC log - record the incident, the quarantine, and begin routine entries immediately.
- Source saffron from a documented supplier with a certificate of analysis and batch number; verify identity before returning it to stock.
- Review other decanted containers for the same defect.
- Retrain dispensers on the rule that no unlabeled material enters a compounded preparation.
Explaining to the patient: Be honest and brief - the ingredient on hand could not be verified for identity and quality, and the clinic will not use unverified material on a patient. Offer an alternative: either a preparation made from verified stock once sourced, or simple wound care with a documented dressing and review. Emphasize this protects them and is standard practice, not a reflection on the therapy itself.